Bristol-Myers Squibb Co. (NYSE: BMY) acquired iPierian, a privately held biotechnology company focused on the discovery and development of new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE